914-948-7740
Deutsch Capital Announces Investment in Conversion Labs

Deutsch Capital Announces Investment in Conversion Labs

Deutsch Capital today announced an investment in Conversion Labs (NASD: CVLB). Conversion Labs is a leading direct-to-patient telehealth company. It provides virtual medical treatment with prescription medications and unique over-the-counter products.

read more
Deutsch Capital Announces Investment in SECOS Group

Deutsch Capital Announces Investment in SECOS Group

Deutsch Capital today announced an investment in SECOS Group (ASE: SES). Australian-based SECOS is a leading developer and manufacturer of sustainable packing materials. Founded in 2002, the company serves its global customers with strategically located manufacturing plants, and sales offices and distributors worldwide.

read more
Deutsch Capital Announces Investment in Curemark

Deutsch Capital Announces Investment in Curemark

Deutsch Capital today announced an investment in Curemark. Established in 2004, Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological and other disorders.

read more
Mark Deutsch Forms Deutsch Capital LLC

Mark Deutsch Forms Deutsch Capital LLC

Mark L. Deutsch, a senior private equity investor with over 30 years of experience, has formed Deutsch Capital to pursue equity investments in the lower middle market. The firm intends to partner with successful management teams to provide resources and guidance to help grow entrepreneurial businesses.

read more
Deutsch Capital Announces Investment in MM.LaFleur

Deutsch Capital Announces Investment in MM.LaFleur

Deutsch Capital today announced an investment in MM.LaFleur. Established this year, MM.LaFleur is an online clothing company for purposeful women. The brand intends to revolutionize the professional women’s apparel industry.

read more